According to our latest research, the global prosthetic joint infections treatment market size reached USD 2.41 billion in 2024, reflecting the growing incidence of joint replacement procedures and subsequent infection risks. The market is expanding at a robust CAGR of 7.6% and is forecasted to reach USD 4.67 billion by 2033. This growth is primarily propelled by the increasing prevalence of prosthetic joint surgeries, the rising geriatric population, and advancements in infection management protocols. As per the latest research, the ongoing development of novel antibiotics and minimally invasive surgical techniques is also contributing significantly to the market’s upward trajectory.
https://growthmarketreports.co....m/report/prosthetic-
